Heron Neutron Medical Corp.
Heron Neutron Medical Corp. develops, manufactures, and sells medical instruments. It offers accelerator-based boron neutron capture therapy solutions, including neutron source target system, accelerator system, target system, beam shaping assembly, treatment control system, treatment planning system, and patient positioning system; and ACSI cyclotron products. The company was founded in 2017 and… Read more
Heron Neutron Medical Corp. (7799) - Total Liabilities
Latest total liabilities as of June 2025: NT$55.34 Million TWD
Based on the latest financial reports, Heron Neutron Medical Corp. (7799) has total liabilities worth NT$55.34 Million TWD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Heron Neutron Medical Corp. - Total Liabilities Trend (2021–2024)
This chart illustrates how Heron Neutron Medical Corp.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Heron Neutron Medical Corp. Competitors by Total Liabilities
The table below lists competitors of Heron Neutron Medical Corp. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
IONOS GROUP N
XETRA:IOS
|
Germany | €1.29 Billion |
|
Baoding Lucky Innovative Materials Co Ltd
SHE:300446
|
China | CN¥4.92 Billion |
|
Montana Aerospace AG
SW:AERO
|
Switzerland | CHF672.59 Million |
|
King’s Town Bank
TW:2809
|
Taiwan | NT$310.19 Billion |
|
Perenti Ltd
AU:PRN
|
Australia | AU$1.25 Billion |
|
Zhe Jiang Dali Technology Co Ltd
SHE:002214
|
China | CN¥726.47 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Heron Neutron Medical Corp.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 26.41 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Heron Neutron Medical Corp.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Heron Neutron Medical Corp. (2021–2024)
The table below shows the annual total liabilities of Heron Neutron Medical Corp. from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$71.96 Million | +150.65% |
| 2023-12-31 | NT$28.71 Million | -29.27% |
| 2022-12-31 | NT$40.59 Million | +534.97% |
| 2021-12-31 | NT$6.39 Million | -- |